Related Experiment Videos
Risk of cancer following splenectomy
M S Linet1, O Nyrén, G Gridley
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
International Journal of Cancer
|May 29, 1996
Summary
Splenectomy for trauma showed no increased cancer risk. However, splenectomy during surgery for adjacent non-malignant conditions was linked to a potential rise in overall cancer incidence, particularly lung and ovarian cancers.
Area of Science:
- Oncology
- Epidemiology
- Surgical Outcomes
Background:
- Limited data exists on cancer risk after splenectomy.
- Previous studies on splenectomized patients are small and population-based.
- Splenectomy is performed for trauma or adjacent non-malignant conditions.
Purpose of the Study:
- To investigate cancer incidence following splenectomy.
- To differentiate cancer risk based on splenectomy indication (trauma vs. adjacent organ surgery).
- To analyze site-specific cancer risks in relation to splenectomy.
Main Methods:
- Swedish nationwide registry linkage (hospitalization, cancer incidence).
- Inclusion of 1,295 patients (trauma) and 985 patients (adjacent organ surgery).
- Calculation of standardized incidence ratios excluding cancers within 12 months post-splenectomy.
Main Results:
- No significant excess of total or site-specific cancers in trauma splenectomy patients.
- A non-significant 40% elevated total cancer risk in patients undergoing splenectomy for adjacent non-malignant conditions.
- Significant increases observed in lung and ovarian cancer risks in the adjacent organ surgery group.
Conclusions:
- Splenectomy for external trauma does not appear to increase cancer risk.
- Elevated lung and ovarian cancer risks following splenectomy for adjacent non-malignant conditions warrant further investigation.
- Potential confounding factors include underlying conditions, treatments, and shared risk factors like smoking.